Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230308 · ClinicalTrials.gov registry record
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
A clinical trial of Head and Neck Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00230308 is a study of Head and Neck Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 500 participants, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (93% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00230308, a study of Head and Neck Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2002-04-02 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230308
The ClinicalTrials.gov registry entry for NCT00230308 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (93% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00230308 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00230308 about?
NCT00230308 is a clinical study titled "Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer". Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
What is the current status of trial NCT00230308?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2002-04-02. Estimated completion is 2030-12.
What conditions does trial NCT00230308 study?
This clinical trial studies the following conditions: Head and Neck Cancer.
Who is sponsoring clinical trial NCT00230308?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00230308 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.